Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France
Editorial Contributor
Senior Scientific Director
Executive Vice President
Director, Scientific Services
Scientific Director
Editorial Contributor
Executive Vice President, Educational Strategy
General Manager, Oncology
This program has been made available online.
Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in the United States, from Clinical Care Options (CCO)
Clinical Care Options (CCO) commentary from Dr Carla Coffin on risks vs benefits of treating patients in the indeterminate category for HBV treatment
Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis
Clinical Care Options (CCO) commentary from Maria Buti, MD, on the interplay between HBV infection and pregnancy
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.